---
title: "NP90425 Faricimab (Vabysmo(r))"
ocid: "ocds-r6ebe6-0000821053"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000821053"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000821053.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000821053.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2026-03-24"
---

# NP90425 Faricimab (Vabysmo(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000821053

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000821053)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000821053.json)

## Summary

The procurement process for supplying Faricimab (Vabysmo®) to NHSScotland has reached the award stage, conducted by The Common Services Agency, also known as NHS National Services Scotland (NSS), situated in Edinburgh, UKM region. This contract is part of the health industry category. The procurement method utilised was limited, specifically an award procedure without prior publication, due to exclusive rights protection. The contract, valued at £48,357,375, was signed on 25 February 2026, with an expected duration of nine months, and options for three additional twelve-month extensions. The framework agreement was awarded to Roche Products Ltd, a large supplier based in Welwyn Garden City, UK.

This tender presents significant opportunities for large pharmaceutical companies with exclusive rights or intellectual property in healthcare supplies, particularly in pharmaceuticals. Businesses equipped with the capability to deliver unique health-related goods under a framework agreement stand to benefit from such procurement processes. The opportunity underscores the importance of exclusive rights in the pharmaceutical industry, encouraging businesses to focus on innovation and the development of proprietary medicinal products to expand within public healthcare contracts. Furthermore, firms specialising in pharmaceutical manufacturing with the capability for large-scale distribution in the UK health sector are particularly well-suited to participate in similar tenders.

## Notice

Supply of Faricimab (Vabysmo(r)) to NHSScotland.

### Lot Information

Lot 1

The Framework Agreement is for the supply of Faricimab (Vabysmo(r)) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework Agreement to one (1) Framework Participant.

### Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR552306 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 24 Mar 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 25 Feb 2026 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £48,357,375 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 24 Mar 2026 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR552306
- 11 Feb 2026 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB549349

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB549349
  NP90425 Faricimab (Vabysmo(r)) - Supply of Faricimab (Vabysmo(r)) to NHSScotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR552306
  NP90425 Faricimab (Vabysmo(r)) - Supply of Faricimab (Vabysmo(r)) to NHSScotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000821053

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000821053. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000821053.json.